Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Investigating Preoperative MPDL3280A in Operable Transitional Cell Carcinoma of the Bladder (ABACUS)

NCT02662309 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT02662309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02662309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Investigating Preoperative MPDL3280A in Operable Transitional Cell Carcinoma of the Bladder (ABACUS)
Lead sponsor
Queen Mary University of London
Phase
Phase 2
Overall status
Completed
Start date
February 1, 2016
Completion date
June 11, 2020
Enrollment
96 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer